Clinical outcomes of a new four-haptic hydrophobic presbyopia-correcting intraocular lens

Abstract A new presbyopia-correcting intraocular lens (IOL) combining bifocal and extended-depth-of-focus profiles (Symbiose: Artis Symbiose Plus; Cristalens Industrie, Lannion, France) was introduced. We compared the output with that of a standard monofocal IOL (PL E: Artis PL E). The two four-haptic hydrophobic IOLs were made of the same material from the same company. Cataract patients bilaterally implanted with either PL E or Symbiose between November 2021 and August 2022 were reviewed. The principal measures of the postoperative results were uncorrected distance visual acuity (UDVA); corrected distance VA (CDVA); uncorrected intermediate VA; uncorrected near VA; objective optical quality; and distance-corrected defocus curves. This study included forty-eight patients (96 eyes), with 22 and 26 patients (44 and 52 eyes, respectively) being implanted with PL E and Symbiose, respectively. All patients received the same type of IOL implanted in both eyes. The average age of patients was 70.9 ± 7.1 and 60.0 ± 8.5 years in PL E and Symbiose groups, respectively, with significantly younger patients in Symbiose group ( p  < 0.001). Both IOLs displayed excellent UDVA and CDVA with no statistical difference ( p  =  0.081 (monocular UDVA), p  =  0.599 (monocular CDVA), p  =  0.204 (binocular UDVA), and p  =  0.145 (binocular CDVA) ). In comparison with PL E group, Symbiose group showed significantly superior postoperative intermediate and near VA ( p  < 0.001). PL E group showed significantly superior objective optical quality compared with Symbiose group ( p  < 0.001). Symbiose provides a continuous range of vision that ensures a seamless transition from far to near with no discontinuity. It also delivers a smooth defocus curve with a larger landing area than the PL E. But the objective optical quality was better in PL E.